Chadwick W Christine

Summary

Affiliation: University of California
Country: USA

Publications

  1. doi request reprint Development of Parkinson's disease in patients with Narcolepsy
    Chadwick W Christine
    Department of Neurology, University of California, San Francisco, 400 Parnassus Avenue, Box 0348, San Francisco, CA 94143, USA
    J Neural Transm 119:697-9. 2012
  2. pmc The neurophysiology and effect of deep brain stimulation in a patient with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism
    Chadwick W Christine
    Department of Neurology, University of California, San Francisco, CA, USA
    J Neurosurg 110:234-8. 2009
  3. pmc Parkinsonism in patients with a history of amphetamine exposure
    Chadwick W Christine
    Department of Neurology, University of California, San Francisco, CA 94143, USA
    Mov Disord 25:228-31. 2010
  4. doi request reprint Long-term evaluation of a phase 1 study of AADC gene therapy for Parkinson's disease
    Gabriele Mittermeyer
    Department of Neurological Surgery, University of California San Francisco, San Francisco, CA 94143, USA
    Hum Gene Ther 23:377-81. 2012
  5. ncbi request reprint Effects of unilateral subthalamic and pallidal deep brain stimulation on fine motor functions in Parkinson's disease
    Ken Nakamura
    Department of Neurology, University of California, San Francisco, CA, USA
    Mov Disord 22:619-26. 2007
  6. doi request reprint Pedunculopontine nucleus deep brain stimulation in a patient with primary progressive freezing gait disorder
    Jill L Ostrem
    Department of Neurology, University of California San Francisco, Center for the Surgical Treatment of Movement Disorders, San Francisco, CA 94143, USA
    Stereotact Funct Neurosurg 88:51-5. 2010
  7. ncbi request reprint Implantation of deep brain stimulators into the subthalamic nucleus: technical approach and magnetic resonance imaging-verified lead locations
    Philip A Starr
    Department of Neurological Surgery, University of California, San Francisco 94143, USA
    J Neurosurg 97:370-87. 2002
  8. doi request reprint Qualitative imaging of adeno-associated virus serotype 2-human aromatic L-amino acid decarboxylase gene therapy in a phase I study for the treatment of Parkinson disease
    Francisco Valles
    Movement Disorder Research Program, Department of Neurological Surgery, University of California, San Francisco, San Francisco, California 94103, USA
    Neurosurgery 67:1377-85. 2010
  9. pmc Cognitive and neuropsychiatric profile of the synucleinopathies: Parkinson disease, dementia with Lewy bodies, and multiple system atrophy
    Aimee W Kao
    Department of Neurology, University of California San Francisco, 94143, USA
    Alzheimer Dis Assoc Disord 23:365-70. 2009
  10. doi request reprint Hospitalization in Parkinson disease: a survey of National Parkinson Foundation Centers
    Kelvin L Chou
    Department of Neurology, University of Michigan, Ann Arbor, MI 48109 5316, USA
    Parkinsonism Relat Disord 17:440-5. 2011

Detail Information

Publications11

  1. doi request reprint Development of Parkinson's disease in patients with Narcolepsy
    Chadwick W Christine
    Department of Neurology, University of California, San Francisco, 400 Parnassus Avenue, Box 0348, San Francisco, CA 94143, USA
    J Neural Transm 119:697-9. 2012
    ..Although preliminary, this observation raises the possibility that some factors intrinsic to narcolepsy or its treatment may be a risk factor for PD...
  2. pmc The neurophysiology and effect of deep brain stimulation in a patient with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism
    Chadwick W Christine
    Department of Neurology, University of California, San Francisco, CA, USA
    J Neurosurg 110:234-8. 2009
    ..This unique case has important implications for translational research that employs the MPTP-primate model for symptomatic therapy in PD...
  3. pmc Parkinsonism in patients with a history of amphetamine exposure
    Chadwick W Christine
    Department of Neurology, University of California, San Francisco, CA 94143, USA
    Mov Disord 25:228-31. 2010
    ....
  4. doi request reprint Long-term evaluation of a phase 1 study of AADC gene therapy for Parkinson's disease
    Gabriele Mittermeyer
    Department of Neurological Surgery, University of California San Francisco, San Francisco, CA 94143, USA
    Hum Gene Ther 23:377-81. 2012
    ..These data indicate stable transgene expression over 4 years after vector delivery and continued safety, but emphasize the need for a controlled efficacy trial and the use of a higher vector dose...
  5. ncbi request reprint Effects of unilateral subthalamic and pallidal deep brain stimulation on fine motor functions in Parkinson's disease
    Ken Nakamura
    Department of Neurology, University of California, San Francisco, CA, USA
    Mov Disord 22:619-26. 2007
    ..Our findings suggest that DBS of the STN or GPi results in a similar improvement in hand movements at short-term follow-up. Preoperative medication responsiveness predicts improvement in some but not other motor tasks...
  6. doi request reprint Pedunculopontine nucleus deep brain stimulation in a patient with primary progressive freezing gait disorder
    Jill L Ostrem
    Department of Neurology, University of California San Francisco, Center for the Surgical Treatment of Movement Disorders, San Francisco, CA 94143, USA
    Stereotact Funct Neurosurg 88:51-5. 2010
    ..We report here on our experience with PPN DBS in treating a 76-year-old man with medication-refractory PPFG...
  7. ncbi request reprint Implantation of deep brain stimulators into the subthalamic nucleus: technical approach and magnetic resonance imaging-verified lead locations
    Philip A Starr
    Department of Neurological Surgery, University of California, San Francisco 94143, USA
    J Neurosurg 97:370-87. 2002
    ..The authors present the technical approach used to implant 76 stimulators into the STNs of patients with PD and the lead locations, which were verified on postoperative magnetic resonance (MR) images...
  8. doi request reprint Qualitative imaging of adeno-associated virus serotype 2-human aromatic L-amino acid decarboxylase gene therapy in a phase I study for the treatment of Parkinson disease
    Francisco Valles
    Movement Disorder Research Program, Department of Neurological Surgery, University of California, San Francisco, San Francisco, California 94103, USA
    Neurosurgery 67:1377-85. 2010
    ....
  9. pmc Cognitive and neuropsychiatric profile of the synucleinopathies: Parkinson disease, dementia with Lewy bodies, and multiple system atrophy
    Aimee W Kao
    Department of Neurology, University of California San Francisco, 94143, USA
    Alzheimer Dis Assoc Disord 23:365-70. 2009
    ..PD, MSA, and DLB groups have similar neuropsychiatric profiles of increased depression and anxiety. Similar underlying alpha-synuclein pathology may contribute to these shared features...
  10. doi request reprint Hospitalization in Parkinson disease: a survey of National Parkinson Foundation Centers
    Kelvin L Chou
    Department of Neurology, University of Michigan, Ann Arbor, MI 48109 5316, USA
    Parkinsonism Relat Disord 17:440-5. 2011
    ..To explore current practices and opinions regarding hospital management of Parkinson disease (PD) patients in specialized PD Centers...
  11. ncbi request reprint Clinical differentiation of parkinsonian syndromes: prognostic and therapeutic relevance
    Chadwick W Christine
    Department of Neurology, School of Medicine, University of California, San Francisco 94143, USA
    Am J Med 117:412-9. 2004
    ..Tests of autonomic function and brain imaging are often helpful in distinguishing these diseases...